A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman, PW O'Connor, E Havrdova… - … England Journal of …, 2006 - Mass Medical Soc
Background Natalizumab is the first α4 integrin antagonist in a new class of selective
adhesion-molecule inhibitors. We report the results of a two-year phase 3 trial of …
adhesion-molecule inhibitors. We report the results of a two-year phase 3 trial of …
[引用][C] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH Polman, PW O'Connor, E Havrdova… - N Engl J …, 2006 - researchportal.tuni.fi
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis —
Tampere University Research Portal Skip to main navigation Skip to search Skip to main …
Tampere University Research Portal Skip to main navigation Skip to search Skip to main …
[引用][C] A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
CH Polman, PW O'Connor, E Havrdova… - New England Journal …, 2006 - cir.nii.ac.jp
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
CH Polman, PW O'Connor, E Havrdova… - The New England …, 2006 - europepmc.org
Background Natalizumab is the first alpha4 integrin antagonist in a new class of selective
adhesion-molecule inhibitors. We report the results of a two-year phase 3 trial of …
adhesion-molecule inhibitors. We report the results of a two-year phase 3 trial of …
[引用][C] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
CH POLMAN, PW O'CONNOR, M TOAL… - The New England …, 2006 - pascal-francis.inist.fr
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …
[PDF][PDF] A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
CH Polman, PW O'Connor, E Havrdova… - N Engl J Med, 2006 - academia.edu
Abstract From the Vrije Universiteit Medical Center, Amsterdam (CHP); St. Michael's
Hospital, Toronto (PWO); General Teaching Hospital, Prague, Czech Republic (EH); St …
Hospital, Toronto (PWO); General Teaching Hospital, Prague, Czech Republic (EH); St …
[PDF][PDF] A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
CH Polman, PW O'Connor, E Havrdova, M Hutchinson… - N Engl J Med, 2006 - Citeseer
Abstract From the Vrije Universiteit Medical Center, Amsterdam (CHP); St. Michael's
Hospital, Toronto (PWO); General Teaching Hospital, Prague, Czech Republic (EH); St …
Hospital, Toronto (PWO); General Teaching Hospital, Prague, Czech Republic (EH); St …
[引用][C] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
CH Polman, PW O'Connor, E Havrdova, M Hutchinson… - 2006 - repository.ubn.ru.nl
BACKGROUND: Natalizumab is the first alpha4 integrin antagonist in a new class of
selective adhesion-molecule inhibitors. We report the results of a two-year phase 3 trial of …
selective adhesion-molecule inhibitors. We report the results of a two-year phase 3 trial of …
[PDF][PDF] A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
CH Polman, PW O'Connor, E Havrdova… - N Engl J …, 2006 - researchgate.net
Abstract From the Vrije Universiteit Medical Center, Amsterdam (CHP); St. Michael's
Hospital, Toronto (PWO); General Teaching Hospital, Prague, Czech Republic (EH); St …
Hospital, Toronto (PWO); General Teaching Hospital, Prague, Czech Republic (EH); St …
[PDF][PDF] A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
CH Polman, PW O'Connor, E Havrdova, M Hutchinson… - N Engl J Med, 2006 - direct-ms.org
Abstract From the Vrije Universiteit Medical Center, Amsterdam (CHP); St. Michael's
Hospital, Toronto (PWO); General Teaching Hospital, Prague, Czech Republic (EH); St …
Hospital, Toronto (PWO); General Teaching Hospital, Prague, Czech Republic (EH); St …
